Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia

Fig. 1

Diversity of SRD5A2 expression of different BPH tissues and cells. (A) Immunohistochemical staining showed that the expression of SRD5A2 was varied in different BPH tissues. Sample 1: negative SRD5A2 expression. Sample 2: weak SRD5A2 expression. Sample 3: strong SRD5A2 expression. No antibody: negative control without incubation with a primary antibody. (B) Varied SRD5A2 expression in BPH tissues. (C)Different SRD5A2 expression in BPH-1 and RWPE-1 cells. Scale bars = 50 μm; ***p ≤ 0.001.SRD5A2: 5-α reductase type 2; BPH: benign prostate hyperplasia; BPH-1: immortalized benign prostatic hyperplasia epithelial cells; RWPE-1: normal prostate epithelial cell line. The original blots/gels are presented in Additional 1: Fig S1

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us